Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121156533 | 12115653 | 3 | F | 2015 | 20160823 | 20160225 | 20160829 | EXP | US-PFIZER INC-2016111859 | PFIZER | 75.00 | YR | F | Y | 68.40000 | KG | 20160829 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121156533 | 12115653 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | Oral | 300MG ONE OR TWO TABLETS TWICE A DAY | Y | 20882 | FILM-COATED TABLET | BID | |||||||
| 121156533 | 12115653 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | SIX 300 TABLETS A DAY | Y | 20882 | 1800 | MG | FILM-COATED TABLET | ||||||
| 121156533 | 12115653 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | SEVEN 300MG TABLETS A DAY | Y | 20882 | 2100 | MG | FILM-COATED TABLET | ||||||
| 121156533 | 12115653 | 4 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | FOUR 300MG TABLETS A DAY | Y | 20882 | 1200 | MG | FILM-COATED TABLET | ||||||
| 121156533 | 12115653 | 5 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 3 DF, DAILY | Y | 20882 | 3 | DF | FILM-COATED TABLET | ||||||
| 121156533 | 12115653 | 6 | SS | NEURONTIN | GABAPENTIN | 1 | Oral | 2 DF, DAILY | Y | 20882 | 2 | DF | FILM-COATED TABLET | ||||||
| 121156533 | 12115653 | 7 | C | DIOVAN | VALSARTAN | 1 | Oral | 160 MG, DAILY | 0 | 160 | MG | TABLET | |||||||
| 121156533 | 12115653 | 8 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 75 UG, DAILY | 0 | 75 | UG | TABLET | ||||||||
| 121156533 | 12115653 | 9 | C | PRAVACHOL | PRAVASTATIN SODIUM | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | TABLET | |||||||
| 121156533 | 12115653 | 10 | C | ACIPHEX | RABEPRAZOLE SODIUM | 1 | Oral | 20 MG, DAILY | 0 | 20 | MG | TABLET | |||||||
| 121156533 | 12115653 | 11 | C | CLARITIN | LORATADINE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
| 121156533 | 12115653 | 12 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 2000 IU, DAILY | 0 | 2000 | IU | TABLET | |||||||
| 121156533 | 12115653 | 13 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 100 MG, DAILY | 0 | 100 | MG | TABLET | |||||||
| 121156533 | 12115653 | 14 | C | CALTRATE +D | 2 | Oral | 600 MG, DAILY | 0 | 600 | MG | TABLET | ||||||||
| 121156533 | 12115653 | 15 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | 1000 MG, DAILY | 0 | 1000 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121156533 | 12115653 | 1 | Trigeminal neuralgia |
| 121156533 | 12115653 | 7 | Hypertension |
| 121156533 | 12115653 | 8 | Thyroid disorder |
| 121156533 | 12115653 | 9 | Blood cholesterol increased |
| 121156533 | 12115653 | 10 | Gastrooesophageal reflux disease |
| 121156533 | 12115653 | 11 | Seasonal allergy |
| 121156533 | 12115653 | 12 | Vitamin D deficiency |
| 121156533 | 12115653 | 13 | Myocardial necrosis marker increased |
| 121156533 | 12115653 | 14 | Mineral supplementation |
| 121156533 | 12115653 | 15 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121156533 | 12115653 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121156533 | 12115653 | Abdominal pain upper | |
| 121156533 | 12115653 | Asthenia | |
| 121156533 | 12115653 | Blood lactate dehydrogenase increased | |
| 121156533 | 12115653 | Crying | |
| 121156533 | 12115653 | Decreased appetite | |
| 121156533 | 12115653 | Depression | |
| 121156533 | 12115653 | Diarrhoea | |
| 121156533 | 12115653 | Dizziness | |
| 121156533 | 12115653 | Drug dependence | |
| 121156533 | 12115653 | Drug ineffective for unapproved indication | |
| 121156533 | 12115653 | Feeling abnormal | |
| 121156533 | 12115653 | Feeling of body temperature change | |
| 121156533 | 12115653 | Gait disturbance | |
| 121156533 | 12115653 | Haematocrit increased | |
| 121156533 | 12115653 | Haemoglobin increased | |
| 121156533 | 12115653 | Headache | |
| 121156533 | 12115653 | Incoherent | |
| 121156533 | 12115653 | Mental disorder | |
| 121156533 | 12115653 | Tachycardia | |
| 121156533 | 12115653 | Thyroxine increased | |
| 121156533 | 12115653 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121156533 | 12115653 | 1 | 20140114 | 0 | ||
| 121156533 | 12115653 | 2 | 201508 | 0 | ||
| 121156533 | 12115653 | 3 | 201509 | 0 | ||
| 121156533 | 12115653 | 4 | 20160122 | 0 | ||
| 121156533 | 12115653 | 5 | 20160127 | 0 | ||
| 121156533 | 12115653 | 6 | 20160201 | 20160205 | 0 |